載入...
CD22ΔE12 as a molecular target for RNAi therapy
B-precursor acute lymphoblastic leukemia (BPL) is the most common form of cancer in children and adolescents. Our recent studies have demonstrated that CD22ΔE12 is a characteristic genetic defect of therapy-refractory clones in pediatric BPL and implicated the CD22ΔE12 genetic defect in the aggressi...
Na minha lista:
| 發表在: | Br J Haematol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486322/ https://ncbi.nlm.nih.gov/pubmed/25659406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13306 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|